Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Version updated to v3.0.2 and the 'Back to Top' link was removed. No evident changes to core content, pricing, stock, or time-slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T18:49:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:17:28.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of specific facility names and locations in Japan, as well as updates to the drug combination information. Notably, the previous version's details about certain diseases and drug components have been removed.
    Difference
    5%
    Check dated 2025-08-31T11:09:06.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T00:58:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T19:57:34.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has added information about a clinical study involving Sofosbuvir/Velpatasvir and Ribavirin for treating chronic Hepatitis C, including details about the study's objectives, eligibility criteria, and outcomes. Additionally, the page now includes a disclaimer stating that the U.S. government does not review or approve all studies listed.
    Difference
    100%
    Check dated 2025-08-02T15:04:34.000Z thumbnail image

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.